{
    "id": 23831,
    "cites": 67,
    "cited_by": 3,
    "reference": [
        "Tirole, Jean. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dOvercoming adverse selection: How public intervention can restore market functioning.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d The American Economic Review 102, no. 1 (2012): 29-59.",
        "Stein, Jeremy C. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dConvertible bonds as backdoor equity financing.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Journal of Financial Economics 32, no. 1 (1992): 3-21.",
        "Ross, Stephen A. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dThe Determination of Financial Structure: The Incentive-Signalling Approach.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Bell Journal of Economics 8, no. 1 (1977): 23-40.",
        "Rampini, Adriano A., and S. Viswanathan. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dCollateral, risk management, and the distribution of debt capacity.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d The Journal of Finance 65, no. 6 (2010): 2293-2322.",
        "Philipson, Tomas J. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c5\u0093Hedging Pipeline Risk in Pharma.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Milken Institute (March 2015).",
        "Philippon, Thomas, and Vasiliki Skreta. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dOptimal Interventions in Markets with Adverse Selection.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d The American Economic Review 102, no. 1 (2012): 1-28.",
        "Nanda, Ramana, and Matthew Rhodes-Kropf. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dFinancing risk and innovation.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Management Science (2016).",
        "Nachman, David C., and Thomas H. Noe. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dOptimal design of securities under asymmetric information.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Review of Financial Studies 7, no. 1 (1994): 1-44.",
        "Myerson, Roger. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dOptimal coordination mechanisms in generalized principal\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00e2\u0080\u009cagent problems.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Journal of Mathematical Economics 10, no. 1 (1982): 67-81.",
        "Myerson, Roger. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dIncentive compatibility and the bargaining problem.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Econometrica 47, no. 1 (1979): 61-73.",
        "Myers, Stewart C., and Nicholas S. Majluf. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dCorporate financing and investment decisions when firms have information that investors do not have.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Journal of Financial Economics 13, no. 2 (1984): 187-221.",
        "Myers, Stewart C., and James A. Read Jr. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c5\u0093Real options, taxes and financial leverage.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d No. w18148. National Bureau of Economic Research, 2012.",
        "Myers, Stewart C. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dCapital structure.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Journal of Economic Perspectives (2001): 81102.",
        "Myers, Stewart C. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dDeterminants of corporate borrowing.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Journal of Financial Economics 5, no. 2 (1977): 147-175.",
        "Modigliani, Franco, and Merton H. Miller. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dThe cost of capital, corporation finance and the theory of investment.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d The American Economic Review (1958): 261-297.",
        "Miller, Merton H. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dDebt and Taxes.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d The Journal of Finance 32, no. 2 (1977): 261-275.",
        "Mann, William. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dCreditor rights and innovation: Evidence from patent collateral.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Available at SSRN 2356015 (2013).",
        "Makarov, Igor, and Guillaume Plantin. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dRewarding trading skills without inducing gambling. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d The Journal of Finance 70, no. 3 (2015): 925-962.",
        "Lim, Steve C., Antonio J. Macias, and Thomas Moeller. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dIntangible Assets and Capital Structure.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Available at SSRN 2514551 (2015).",
        "Leland, Hayne E. and David H. Pyle. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dInformational asymmetries, financial structure, and financial intermediation.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d The Journal of Finance 32, no. 2 (1977): 371-387.",
        "Lerner, Josh, Hilary Shane, and Alexander Tsai. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dDo equity financing cycles matter ? Evidence from biotechnology alliances.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Journal of Financial Economics 67, no. 3 (2003): 411-446.",
        "Kamien, Morton I., and Nancy L. Schwartz. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dSelf-Financing of an R and D Project.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d The American Economic Review 68, no. 3 (1978): 252-261.",
        "J\u00c3\u0083\u00c6\u0092\u00c3\u0082\u00c2\u00b8rring, Adam, Andrew W. Lo, Tomas J. Philipson, Manita Singh, and Richard T. Thakor. Sharing R&D Risk in Healthcare via FDA Hedges. No. w23344. National Bureau of Economic Research, 2017.",
        "Jensen, Michael C., and William H. Meckling. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dTheory of the firm: Managerial behavior, agency costs and ownership structure.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Journal of Financial Economics 3, no. 4 (1976): 305-360.",
        "Hsu, Po-Hsuan, Xuan Tian, and Yan Xu. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dFinancial development and innovation: Cross-country evidence.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Journal of Financial Economics 112, no. 1 (2014): 116-135.",
        "Holmstrom, Bengt. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c5\u0093Understanding the Role of Debt in the Financial System.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d BIS Working Papers No. 479. Bank for International Settlements, 2015.",
        "Himmelberg, Charles P., and Bruce C. Petersen. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dR&D and Internal Finance: A Panel Study of Small Firms in High-Tech Industries.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d The Review of Economics and Statistics 76, no. 1 (1994): 38-51.",
        "Hellwig, Martin F. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dA reconsideration of the Jensen-Meckling model of outside finance.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Journal of Financial Intermediation 18, no. 4 (2009): 495-525.",
        "He, Zhaozhao and Wintoki, M. Babajide, The Cost of Innovation: R&D and High Cash Holdings in U.S. Firms (September 16, 2014). Available at SSRN: http://ssrn.com/abstract=2322029 or http://dx.doi.org/10.2139/ssrn.2322029",
        "Harris, Milton, and Artur Raviv. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dThe theory of capital structure.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d The Journal of Finance 46, no. 1 (1991): 297-355.",
        "Hart, Oliver, and John Moore. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dA Theory of Debt Based on the Inalienability of Human Capital.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d The Quarterly Journal of Economics 109, no. 4 (1994): 841-879.",
        "Halov, Nikolay, and Florian Heider. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dCapital structure, risk and asymmetric information. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d The Quarterly Journal of Finance 1, no. 04 (2011): 767-809.",
        "Hall, Bronwyn H., and Josh Lerner. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dThe Financing of R&D and Innovation.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Handbook of the Economics of Innovation 1 (2010): 609-639.",
        "Green, Richard C. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dInvestment incentives, debt, and warrants.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Journal of Financial Economics 13, no. 1 (1984): 115-136.",
        "Grabowski, Henry, John Vernon, and Joseph A. DiMasi. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dReturns on research and development for 1990s new drug introductions.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Pharmacoeconomics 20, no. 3 (2002): 11-29.",
        "Grabowski, Henry, and John Vernon. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dA new look at the returns and risks to pharmaceutical R&D.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Management Science 36, no. 7 (1990): 804-821.",
        "Gertner, Robert, Robert Gibbons, and David Scharfstein. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dSimultaneous Signalling to the Capital and Product Markets.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d RAND Journal of Economics 19, no. 2 (1988): 173-190.",
        "Fulghieri, Paolo, Diego Garcia, and Dirk Hackbarth. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c5\u0093Asymmetric information, security design, and the pecking (dis) order.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d No. 10660. CEPR Discussion Papers, 2015.",
        "Frank, Murray Z., and Vidhan K. Goyal. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dTrade-off and pecking order theories of debt.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Handbook of Empirical Corporate Finance 2 (2005): 135-202.",
        "Fluck, Zsuzsanna. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dOptimal financial contracting: Debt versus outside equity.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Review of Financial Studies 11, no. 2 (1998): 383-418.",
        "Fernandez, Jose-Maria, Roger M. Stein, and Andrew W. Lo. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dCommercializing biomedical research through securitization techniques.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Nature Biotechnology 30, no. 10 (2012): 964-975.",
        "Abel, Andrew B. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c5\u0093Optimal Debt and Profitability in the Tradeoff Theory.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Working Paper, 2014.",
        "Zwiebel, Jeffrey. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dDynamic capital structure under managerial entrenchment.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d The American Economic Review (1996): 1197-1215.",
        "Townsend, Robert M. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dOptimal contracts and competitive markets with costly state verification.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Journal of Economic Theory 21, no. 2 (1979): 265-293.",
        "Thakor, Richard T., Nicholas Anaya, Yuwei Zhang, Christian Vilanilam, Kien Wei Siah, Chi Heem Wong, and Andrew W. Lo.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c5\u0093Just how good an investment is the biopharmaceutical sector?\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d. Working Paper, 2017.",
        "Thakor, Richard T., and Andrew W. Lo. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c5\u0093Competition and R&D Financing Decisions: Evidence from the Biopharmaceutical Industry.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Working Paper, 2016.",
        "Eckbo, B. Espen. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dCorporate Takeovers: Modern Empirical Developments.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d (2011).",
        "DiMasi, Joseph A., Janice M. Reichert, Lanna Feldman, and Ashley Malins. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dClinical approval success rates for investigational cancer drugs.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Clinical Pharmacology & Therapeutics 94, no. 3 (2013): 329-335.",
        "DiMasi, Joseph A., Ronald W. Hansen, Henry G. Grabowski, and Louis Lasagna. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dCost of innovation in the pharmaceutical industry.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Journal of Health Economics 10, no. 2 (1991): 107-142.",
        "DiMasi, Joseph A., Henry G. Grabowski, and John Vernon. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dR&D costs and returns by therapeutic category.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Drug Information Journal 38, no. 3 (2004): 211-223.",
        "DiMasi, J. A., H. G. Grabowski, and R. W. Hansen. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dInnovation in the pharmaceutical industry: new estimates of R&D costs.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Medford, MA: Tufts Center for the Study of Drug Development (2014).",
        "DiMasi, Joseph A., and Henry G. Grabowski. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dThe cost of biopharmaceutical R&D: is biotech different?.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Managerial and Decision Economics 28, no. 4-5 (2007): 469-479.",
        "DeAngelo, Harry, and Ronald W. Masulis. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dOptimal capital structure under corporate and personal taxation.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Journal of Financial Economics 8, no. 1 (1980): 3-29.",
        "Byoun, Soku, William T. Moore, and Zhaoxia Xu. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dWhy do some firms become debtfree. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Unpublished working paper, Baylor University (2008).",
        "Brown, James R., Steven M. Fazzari, and Bruce C. Petersen. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dFinancing innovation and growth: Cash flow, external equity, and the 1990s R&D boom.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d The Journal of Finance 64, no. 1 (2009): 151-185.",
        "Brown, James R., and Bruce C. Petersen. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dCash holdings and R&D smoothing.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Journal of Corporate Finance 17, no. 3 (2011): 694-709.",
        "Bradley, Michael, Gregg A. Jarrell, and E. Kim. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dOn the existence of an optimal capital structure: Theory and evidence.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d The Journal of Finance 39, no. 3 (1984): 857-878.",
        "Brennan, Michael, and Alan Kraus. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dEfficient financing under asymmetric information.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d The Journal of Finance 42, no. 5 (1987): 1225-1243.",
        "Bolton, Patrick, Hui Chen, and Neng Wang. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c5\u0093Debt, Taxes, and Liquidity.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d No. w20009. National Bureau of Economic Research, 2014.",
        "Bhattacharya, Sudipto, and Gabriella Chiesa. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dProprietary information, financial intermediation, and research incentives.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Journal of Financial Intermediation 4, no. 4 (1995): 328-357.",
        "Begenau, Juliane, and Berardino Palazzo. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dFirm Selection and Corporate Cash Holdings. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Harvard Business School Finance Working Paper 16-130 (2016).",
        "Bates, Thomas W., Kathleen M. Kahle, and Rene\u00c3\u0083\u00c5\u0092\u00c3\u0082\u00c2\u0081 M. Stulz. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dWhy do US firms hold so much more cash than they used to?.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d The Journal of Finance 64, no. 5 (2009): 1985-2021.",
        "Baron, David P., and Roger B. Myerson. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dRegulating a monopolist with unknown costs.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Econometrica (1982): 911-930.",
        "Banks, Jeffrey, and Joel Sobel. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dEquilibrium Selection in Signaling Games.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Econometrica 55, no. 3 (1987): 647-61.",
        "Aumann, Robert J., and Micha Perles. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dA variational problem arising in economics.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Journal of Mathematical Analysis and Applications 11 (1965): 488-503.",
        "Aghion, Philippe, and Jean Tirole. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009dThe management of innovation.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d The Quarterly Journal of Economics (1994): 1185-1209.",
        "Acharya, Viral V., and Zhaoxia Xu. \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c5\u0093Financial dependence and innovation: The case of public versus private firms.\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d No. w19708. National Bureau of Economic Research, 2013."
    ]
}